difficult make firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes|difficult make firm conclusitons best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes
difficult make firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes|difficult make firm conclusions bset treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes
difficult make firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes|difficult make firm concluisons best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes
difficult make firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes|difficult make firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-erm monitoring patient outcomes
difficult make firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes|difficult maek firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes
difficult make firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes|difficult make firm conclusions best toreatment especially regarding long‐term benefit safety early toreatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes
difficult make firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes|difficult make firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing diseaise modifying therapies long-term monitoring patient outcomes
difficult make firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes|difficult make firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disaese modifying therapies long-term monitoring patient outcomes
difficult make firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes|difficult make firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patint outcomes
difficult make firm conclusions best treatment especially regarding long‐term benefit safety early treatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes|difficult make firm conclusions best reatment especially regarding long‐term benefit safety early reatment given lack studies directly comparing disease modifying therapies long-term monitoring patient outcomes
